Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 1

Status

Completed 44Unknown 19Recruiting 9Withdrawn 6Terminated 4Not yet recruiting 3Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Observational 4Interventional 4

Sponsor

Cancer Type

Gastrointestinal 2Head & Neck 1Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Pancreatic Neoplasms 1Melanoma 1Colorectal Neoplasms 1

Interventions

Cyclophosphamide 389Carboplatin 343Gemcitabine 331pembrolizumab 328Cisplatin 327Paclitaxel 294Radiotherapy 291Docetaxel 285Bevacizumab 249Rituximab 233Capecitabine 221Nivolumab 218Dexamethasone 205Fluorouracil 189fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 133Bortezomib 129fludarabine phosphate 128Cetuximab 126Lenalidomide 125Filgrastim 119Erlotinib Hydrochloride 119Temozolomide 111Radiosurgery 110

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Interventional × Electroporation × Clear all
NCT05609656 2024-06-03

ELI

Zealand University Hospital

Phase 2 Terminated
4 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT05435053 2023-09-15

CHECKPOINT

Zealand University Hospital

Phase 2 Terminated
9 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT03823131 2023-05-09

Optimizing Antitumor Immunity Using Plasmid Electroporation, Pembrolizumab, and Epacadostat

University of California, San Francisco

Phase 2 Terminated
14 enrolled 12 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT01045915 2015-09-11

AMEP

Valerio Therapeutics

Phase 1 Terminated
5 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡